Medicine and Dentistry
Clear Cell Renal Cell Carcinoma
100%
Kidney Cancer
59%
Partial Nephrectomy
42%
Neoplasm
39%
Kidney Tumour
36%
Malignant Neoplasm
30%
Bladder
26%
Surgeon
25%
Bladder Cancer
25%
Overall Survival
23%
C Reactive Protein
23%
Surgery
22%
Cystectomy
21%
Recurrence Free Survival
20%
Recurrent Disease
20%
Transitional Cell Carcinoma
19%
Urethroplasty
18%
Systemic Therapy
18%
Gemcitabine
18%
Urologist
17%
Hazard Ratio
17%
Cancer
16%
Disease
16%
Cancer Mortality
15%
Docetaxel
15%
Sarcomatoid
15%
Cancer Specific Survival
15%
Glomerular Filtration Rate
14%
Kaplan Meier Method
14%
Sunitinib
14%
Radical Nephrectomy
14%
Neoadjuvant Therapy
13%
Adjuvant Therapy
12%
Urinary Tract
12%
Cisplatin
12%
Prostate Cancer
12%
Stricture
11%
Metastatic Carcinoma
11%
Surgical Margin
11%
Odds Ratio
10%
Papillary Renal Cell Carcinomas
10%
Quality of Life
10%
Germinoma
10%
Bladder Tumor
9%
Muscle Invasive Bladder Cancer
9%
Neoadjuvant Chemotherapy
9%
Immunotherapy
8%
Cohort Analysis
8%
Decision Making
8%
Chronic Kidney Disease
8%
Keyphrases
Renal Cell Carcinoma
45%
Partial Nephrectomy
31%
Renal Cancer
23%
Bladder Cancer
21%
Trifecta
19%
PT3a
19%
Overall Survival
17%
Trifecta Outcomes
17%
Recurrence-free Survival
16%
Renal Mass
15%
National Cancer Database
15%
Kidney Cancer
15%
Elderly People
15%
Metastatic Renal Cell Carcinoma (mRCC)
15%
Hazard Ratio
15%
Multivariable
14%
Functional Outcome
14%
Cancer-specific Survival
13%
Urologists
12%
Small Renal Mass
12%
Tumor
11%
Survival Outcomes
11%
Gemcitabine
11%
Sarcomatoid
11%
Estimated Glomerular Filtration Rate
11%
Radical Nephrectomy
11%
Risk Factors
9%
Muscle-invasive Bladder Cancer
9%
Surgical Management
9%
African American
9%
Single Surgeon
8%
Cisplatin
8%
Testosterone
8%
Quality Outcomes
8%
Recurrence Risk
8%
Neoadjuvant Therapy
8%
Odds Ratio
8%
Comparative Analysis
8%
Definitive Treatment
7%
Pathological Diagnosis
7%
Robot-assisted
7%
Population-based Cohort Study
7%
3-cycle
7%
Prostate Cancer Risk
7%
Testicular Germ Cell Tumor
7%
Open Partial Nephrectomy
7%
Over 75
7%
Bulbar Urethroplasty
7%
International Analysis
7%
Pediatric
7%